A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles

Amber L Southwell, Niels H Skotte, Erika B Villanueva, Michael E Østergaard, Xiaofeng Gu, Holly B Kordasiewicz, Chris Kay, Daphne Cheung, Yuanyun Xie, Sabine Waltl, Louisa Dal Cengio, Hailey Findlay-Black, Crystal N Doty, Eugenia Petoukhov, Diepiriye Iworima, Ramy Slama, Jolene Ooi, Mahmoud A Pouladi, X William Yang, Eric E SwayzePunit P Seth, Michael R Hayden

    11 Citations (Scopus)

    Abstract

    Huntington disease (HD) is a neurodegenerative disease caused by a mutation in the huntingtin (HTT) gene. HTT is a large protein, interacts with many partners and is involved in many cellular pathways, which are perturbed in HD. Therapies targeting HTT directly are likely to provide the most global benefit. Thus there is a need for preclinical models of HD recapitulating human HTT genetics. We previously generated a humanized mouse model of HD, Hu97/18, by intercrossing BACHD and YAC18 mice with knockout of the endogenous mouse HD homolog (Hdh). Hu97/18 mice recapitulate the genetics of HD, having two full-length, genomic human HTT transgenes heterozygous for the HD mutation and polymorphisms associated with HD in populations of Caucasian descent. We have now generated a companion model, Hu128/21, by intercrossing YAC128 and BAC21 mice on the Hdh-/- background. Hu128/21 mice have two full-length, genomic human HTT transgenes heterozygous for the HD mutation and polymorphisms associated with HD in populations of East Asian descent and in a minority of patients from other ethnic groups. Hu128/21 mice display a wide variety of HD-like phenotypes that are similar to YAC128 mice. Additionally, both transgenes in Hu128/21 mice match the human HTT exon 1 reference sequence. Conversely, the BACHD transgene carries a floxed, synthetic exon 1 sequence. Hu128/21 mice will be useful for investigations of human HTT that cannot be addressed in Hu97/18 mice, for developing therapies targeted to exon 1, and for preclinical screening of personalized HTT lowering therapies in HD patients of East Asian descent.

    Original languageEnglish
    JournalHuman Molecular Genetics
    Volume26
    Issue number6
    Pages (from-to)1115-1132
    Number of pages18
    ISSN0964-6906
    DOIs
    Publication statusPublished - 15 Mar 2017

    Keywords

    • Alleles
    • Animals
    • Disease Models, Animal
    • Exons
    • Heterozygote
    • Humans
    • Huntingtin Protein
    • Huntington Disease
    • Mice
    • Mice, Transgenic
    • Mutation
    • Phenotype
    • Journal Article
    • Research Support, Non-U.S. Gov't

    Fingerprint

    Dive into the research topics of 'A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles'. Together they form a unique fingerprint.

    Cite this